众生药业：盐酸氨溴索口服溶液获药品注册证书

Core Viewpoint - The company, Zhongsheng Pharmaceutical, has received approval from the National Medical Products Administration for the registration of its oral solution of Ambroxol Hydrochloride, which is indicated for the treatment of bronchitis-related symptoms [1] Group 1 - The oral solution of Ambroxol Hydrochloride is suitable for both acute and chronic bronchitis, specifically addressing issues related to thick phlegm and difficulty in expectoration [1] - The product has clear diagnostic and treatment guidelines recommended for its use [1]